Latest filing published 29 May 2026 for Bausch + Lomb Corporation.
Filing timeline
BuySaleInsider track record
Sarah Baldwin Kavanagh: trading record in brief
Sarah Baldwin Kavanagh has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Bausch + Lomb Corporation and Bausch Health Companies Inc. Over a trading history stretching from 5 May 2022 to 26 May 2026, the count stands at 5 filings.
The open-market record consists of 1 sale worth €77k, with no purchase. Outside the open market, there are 2 share grants and 1 option exercise.
The latest filing, published on 29 May 2026, reports a share grant in Bausch + Lomb Corporation. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Sarah Baldwin Kavanagh
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 15,842 sharesRights Restricted Share UnitsTSXSEDI:4725242
- 45,871 sharesRights Restricted Share Units (RSUs)TSXSEDI:4723823
- Common SharesTSXSEDI:4120399
- 6,692 shares@ CA$17.1234.9% of flowCommon SharesTSXSEDI:4120401
- 12,500 shares@ CA$17.1265.1% of flowCommon SharesTSXSEDI:4120400
5 of 5 declarations
